News and media coverage Articles Karma El Chalabi 12/20/24 Articles Karma El Chalabi 12/20/24 Premature Ejaculation in the Media… Read More Articles Karma El Chalabi 11/26/24 Articles Karma El Chalabi 11/26/24 Sejelas: Founder-CEO Interview Series Read More Articles Karma El Chalabi 10/10/24 Articles Karma El Chalabi 10/10/24 Start-up Spotlight: Kadence Bio Pioneers Innovative Therapies for Sexual and Mental Health Read More Karma El Chalabi 9/23/24 Karma El Chalabi 9/23/24 Kadence Bio Selected for Zcube-Zambon Research Venture's Open Accelerator Read More Karma El Chalabi 9/19/24 Karma El Chalabi 9/19/24 Kadence Bio’s Role in an Enhanced Future Read More Posts Karma El Chalabi 9/3/24 Posts Karma El Chalabi 9/3/24 Kanna Health is Now Kadence Bio! Read More Posts AB 5/29/24 Posts AB 5/29/24 Kadence Bio obtains B-Corp certification! Read More Posts Karma El Chalabi 5/9/24 Posts Karma El Chalabi 5/9/24 Kadence Bio Graduates from Endless Frontier Labs Accelerator Program Read More Press Releases Karma El Chalabi 11/16/23 Press Releases Karma El Chalabi 11/16/23 Kanna Health (now Kadence Bio) announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation Read More Press Releases Karma El Chalabi 1/26/23 Press Releases Karma El Chalabi 1/26/23 Kanna Health (now Kadence Bio) announces patent application publication Read More Posts Karma El Chalabi 11/18/22 Posts Karma El Chalabi 11/18/22 Kadence Bio attends the International Society for Sexual Medicine (ISSM) conference 2022 Read More Articles Karma El Chalabi 8/9/22 Articles Karma El Chalabi 8/9/22 People | Product | Potential Special Edition on the World's Indigenous People International Day Read More Press Releases Karma El Chalabi 6/30/22 Press Releases Karma El Chalabi 6/30/22 Kanna Health (now Kadence Bio) announces patent application publication for KH-001 as premature ejaculation treatment Read More
Articles Karma El Chalabi 12/20/24 Articles Karma El Chalabi 12/20/24 Premature Ejaculation in the Media… Read More
Articles Karma El Chalabi 11/26/24 Articles Karma El Chalabi 11/26/24 Sejelas: Founder-CEO Interview Series Read More
Articles Karma El Chalabi 10/10/24 Articles Karma El Chalabi 10/10/24 Start-up Spotlight: Kadence Bio Pioneers Innovative Therapies for Sexual and Mental Health Read More
Karma El Chalabi 9/23/24 Karma El Chalabi 9/23/24 Kadence Bio Selected for Zcube-Zambon Research Venture's Open Accelerator Read More
Posts Karma El Chalabi 9/3/24 Posts Karma El Chalabi 9/3/24 Kanna Health is Now Kadence Bio! Read More
Posts Karma El Chalabi 5/9/24 Posts Karma El Chalabi 5/9/24 Kadence Bio Graduates from Endless Frontier Labs Accelerator Program Read More
Press Releases Karma El Chalabi 11/16/23 Press Releases Karma El Chalabi 11/16/23 Kanna Health (now Kadence Bio) announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation Read More
Press Releases Karma El Chalabi 1/26/23 Press Releases Karma El Chalabi 1/26/23 Kanna Health (now Kadence Bio) announces patent application publication Read More
Posts Karma El Chalabi 11/18/22 Posts Karma El Chalabi 11/18/22 Kadence Bio attends the International Society for Sexual Medicine (ISSM) conference 2022 Read More
Articles Karma El Chalabi 8/9/22 Articles Karma El Chalabi 8/9/22 People | Product | Potential Special Edition on the World's Indigenous People International Day Read More
Press Releases Karma El Chalabi 6/30/22 Press Releases Karma El Chalabi 6/30/22 Kanna Health (now Kadence Bio) announces patent application publication for KH-001 as premature ejaculation treatment Read More
